APOE and Alzheimer disease: If we focus on AD as a continuum as per NIA-AA [181], i.e., progressive cognitive decline along the progression of biomarker measures, we have APOE3 and 4 MMC children and young adults in the Alzheimer continuum from the first decade on, with a striking significant accelerated progression in young APOE4 carriers.